NCT03085147 2026-02-12
A Dye for the Detection of Cancer of the Tongue and Mouth
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
Clinical Trials
4 trialsNCT05366166 2026-01-28
Pembrolizumab Plus Olaparib in LA-HNSCC
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT04643379 2025-10-22
Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Washington University School of Medicine
Phase 2 Active not recruiting
NCT02308072 2024-05-08
ORCA-2
University College, London
Phase 1 Active not recruiting